# Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS: Phase 2 study closed enrollment, 19 enrolled (Stage IV Colorectal Cancer, Curative Resection)

**Score:** 70/100

| Field | Value |
|---|---|
| Sponsor | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
| Sponsor type | Academic and hospital |
| Study | Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. |
| NCT ID | NCT02919644 |
| Phase | Phase 2 |
| Status | active not recruiting |
| Conditions | Stage IV Colorectal Cancer; Curative Resection |
| Intervention types | biological, drug |
| Target enrollment | 19 |
| Site countries | Italy |
| Posted | 2016-09-29 |
| Planned start | 2016-12-02 |
| Event | Enrollment closed (active, not recruiting) |
| Event date | 2026-10-28 |
| Last update posted | 2026-10-28 |

## Why this score
- Posted in the last two weeks.
- Enrollment closed: data management, monitoring and closeout ahead.
- Phase 2: multi-site, larger budget.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT02919644). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.